Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)

Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y) Publisher Pubmed

Dastgheib M¹ ; Shetabboushehri SV¹ ; Baeeri M² ; Gholami M² ; Karimi MY¹ ; Hosseini A¹

Show Affiliations

1. Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran
2. Department of Toxicology and Pharmacology, School of Pharmacy, and Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran

Source: Metabolic Brain Disease Published:2024

Abstract

The original version of this article unfortunately contained an error in Fig. 8 where the image of HE-stained DRG neurons was mistakenly placed. In this correction, we have now provided the corrected Fig. 8 by replacing the image of HE-stained DRG neurons with the correct image. The authors declare this inadvertent error does not affect the results and conclusion of this paper. (Figure presented.). © 2023, Springer Science+Business Media, LLC, part of Springer Nature.

Style	Citing Format
MLA	Dastgheib M, et al.. "Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)." Metabolic Brain Disease, vol. 39, no. 1, 2024, pp. 253-254.
APA	Dastgheib M, Shetabboushehri SV, Baeeri M, Gholami M, Karimi MY, Hosseini A (2024). Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y). Metabolic Brain Disease, 39(1), 253-254.
Chicago	Dastgheib M, Shetabboushehri SV, Baeeri M, Gholami M, Karimi MY, Hosseini A. "Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)." Metabolic Brain Disease 39, no. 1 (2024): 253-254.
Harvard	Dastgheib M et al. (2024) 'Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)', Metabolic Brain Disease, 39(1), pp. 253-254.
Vancouver	Dastgheib M, Shetabboushehri SV, Baeeri M, Gholami M, Karimi MY, Hosseini A. Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y). Metabolic Brain Disease. 2024;39(1):253-254.
BibTex	@article{ author = {Dastgheib M and Shetabboushehri SV and Baeeri M and Gholami M and Karimi MY and Hosseini A}, title = {Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)}, journal = {Metabolic Brain Disease}, volume = {39}, number = {1}, pages = {253-254}, year = {2024} }
RIS	TY - JOUR AU - Dastgheib M AU - Shetabboushehri SV AU - Baeeri M AU - Gholami M AU - Karimi MY AU - Hosseini A TI - Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y) JO - Metabolic Brain Disease VL - 39 IS - 1 SP - 253 EP - 254 PY - 2024 ER -

Style

Citing Format

MLA

Dastgheib M, et al.. "Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)." Metabolic Brain Disease, vol. 39, no. 1, 2024, pp. 253-254.

APA

Dastgheib M, Shetabboushehri SV, Baeeri M, Gholami M, Karimi MY, Hosseini A (2024). Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y). Metabolic Brain Disease, 39(1), 253-254.

Chicago

Dastgheib M, Shetabboushehri SV, Baeeri M, Gholami M, Karimi MY, Hosseini A. "Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)." Metabolic Brain Disease 39, no. 1 (2024): 253-254.

Harvard

Dastgheib M et al. (2024) 'Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)', Metabolic Brain Disease, 39(1), pp. 253-254.

Vancouver

Dastgheib M, Shetabboushehri SV, Baeeri M, Gholami M, Karimi MY, Hosseini A. Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y). Metabolic Brain Disease. 2024;39(1):253-254.

BibTex

@article{ author = {Dastgheib M and Shetabboushehri SV and Baeeri M and Gholami M and Karimi MY and Hosseini A}, title = {Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)}, journal = {Metabolic Brain Disease}, volume = {39}, number = {1}, pages = {253-254}, year = {2024} }

RIS

TY - JOUR
AU - Dastgheib M
AU - Shetabboushehri SV
AU - Baeeri M
AU - Gholami M
AU - Karimi MY
AU - Hosseini A
TI - Correction To: Rolipram and Pentoxifylline Combination Ameliorates Experimental Diabetic Neuropathy Through Inhibition of Oxidative Stress and Inflammatory Pathways in the Dorsal Root Ganglion Neurons (Metabolic Brain Disease, (2022), 37, 7, (2615-2627), 10.1007/S11011-022-01060-Y)
JO - Metabolic Brain Disease
VL - 39
IS - 1
SP - 253
EP - 254
PY - 2024
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract